Dublin, June 16, 2021 (GLOBE NEWSWIRE) — The “Autoimmune Disease Diagnostics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s providing.
The autoimmune illness diagnostics market is predicted to register a CAGR of almost 8.3% throughout the forecast interval. The rising consciousness about autoimmune illnesses by way of applications of analysis, schooling, assist, and advocacy is a key issue boosting the utilization charges of autoimmune illness diagnostics, globally.
The US has the best incidence of autoimmune illnesses, whereby about 50 million sufferers undergo from autoimmune illnesses. In line with Arthritis Basis, in 2017 about 54.4 million adults in america undergo from recognized arthritis. Moreover, in accordance with the 2017 report of the Worldwide Diabetes Federation (IDF), roughly 425 million adults (20-79 years) had been affected by diabetes, and by 2045 this quantity could rise to 629 million, globally.
Authorities organizations and NGOs goals to extend consciousness concerning the socioeconomic impression of autoimmunity by way of fostering and facilitating collaboration within the areas of schooling, public consciousness, analysis, and affected person providers in an efficient, moral, and environment friendly method.
The opposite elements, comparable to improved laboratory automation, partnerships with physicians and medical laboratories, and technological developments, are driving the autoimmune illness diagnostics market. Nonetheless, the sluggish turnaround time of the analysis and excessive frequency of false outcomes are hindering the expansion of the autoimmune illness diagnostics market.
Key Market Traits
Rheumatoid Arthritis Section is Anticipated to Maintain a Main Market Share within the Autoimmune Illness Diagnostics Market
Rheumatoid arthritis (RA) is an autoimmune illness that primarily assaults the synovial tissues inside the joints. The illness predominantly impacts aged sufferers. The ageing inhabitants coupled with technological developments in immunofluorescence and proteomics applied sciences will additional improve the rheumatoid arthritis analysis influencing the section development.
The rising prevalence of illnesses comparable to rheumatoid arthritis, Hashimoto’s thyroiditis, and the presence of favorable authorities laws will render a major impression on the autoimmune illness diagnostics market development. As per the American Autoimmune Associated Ailments Affiliation, round 50 million People presently undergo from autoimmune-related issues. Furthermore, the numbers are anticipated to escalate over the forecast interval. The demand for higher and exact diagnostic strategies, together with the rising prevalence, is predicted to extend over the forecast interval.
Asia-Pacific is the Quickest Rising Area within the Autoimmune Illness Diagnostics Market
Asia-Pacific is anticipated to exhibit in depth market development over the forecast interval, owing to the presence of rising disposable earnings and rising affected person pool in rising nations. Moreover, rising consciousness relating to the advantages of early and correct analysis of autoimmune illnesses to hunt proper remedy, rising growth of healthcare infrastructure, and rising healthcare expenditure are more likely to increase the expansion of the autoimmune illness diagnostics market within the Asia-Pacific area.
Progress methods adopted by the native and worldwide gamers within the Asia-Pacific area can be propelling the expansion of the autoimmune illness diagnostics market. In 2017, ImmunArray, a privately-held molecular system diagnostic firm, and Kindstar World Co. Ltd, a speciality medical testing firm primarily based in Wuhan, solid a partnership to undertake joint medical testing for lupus, as a result of rising prevalence of the illness in China.
The Autoimmune Illness Diagnostics Market is fragmented aggressive. The market contains of main market gamers, and these gamers are specializing in R&D actions and vital development methods. Lately, a couple of diagnostic corporations entered into strategic partnerships with hospitals. This pattern is predicted to proceed over the following few years, with the intention to meet the excessive quantity of affected person wants, throughout completely different areas.
In July 2017, AARDA, in partnership with the Relapsing Polychondritis Consciousness & Assist Basis (RPASF), hosted the primary Bowling Inexperienced Autoimmune Stroll and Warriors 5K Enjoyable Run to lift consciousness and funding for modern analysis. In Might 2017, Thermo Fisher Scientific acquired Patheon.
In June 2017, Bio-Rad signed an settlement with VISIA imaging for fully-automated IFA Slide Processing and Studying System. Thus, the market has been witnessing technological developments on a big scale for the previous couple of years.
Key Matters Lined:
1.1 Examine Deliverables
1.2 Examine Assumptions
1.3 Scope of the Examine
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Autoimmune Ailments and Rising Public Consciousness?
4.2.2 Technological Developments and Improved Laboratory Automation?
4.3 Market Restraints
4.3.1 Gradual Turnaround Time of Outcomes and Want for A number of Diagnostic Exams
4.3.2 Excessive Price and Reimbursement Points Coupled with Regulatory Uncertainties
4.4 Porter’s 5 Forces Evaluation
4.4.1 Menace of New Entrants
4.4.2 Bargaining Energy of Patrons/Customers
4.4.3 Bargaining Energy of Suppliers
4.4.4 Menace of Substitute Merchandise
4.4.5 Depth of Aggressive Rivalry
5 MARKET SEGMENTATION
5.1 Illness Sort
5.1.1 Systemic Autoimmune Illness
184.108.40.206 Rheumatoid Arthritis
220.127.116.11 Systemic Lupus Erythematosus (SLE)
18.104.22.168 A number of Sclerosis
22.214.171.124 Different Systemic Autoimmune Ailments
5.1.2 Localized Autoimmune Illness
126.96.36.199 Inflammatory Bowel Illness
188.8.131.52 Sort 1 Diabetes
184.108.40.206 Different Localized Autoimmune Ailments
5.2 By Prognosis
5.2.1 Antinuclear Antibody Exams?
5.2.2 Autoantibody Exams?
5.2.3 Full Blood Depend (CBC)?
5.2.4 C-reactive Protein (CRP)?
5.2.6 Others checks
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Remainder of Europe
126.96.36.199 South Korea
188.8.131.52 Remainder of Asia-Pacific
5.3.4 Center-East & Africa
184.108.40.206 South Africa
220.127.116.11 Remainder of Center-East & Africa
5.3.5 South America
18.104.22.168 Remainder of South America
6 COMPETITIVE LANDSCAPE
6.1 Firm Profiles
6.1.1 Abbott Laboratories
6.1.3 Bio-rad Laboratories
6.1.4 Euroimmun AG
6.1.5 F. Hoffmann-la Roche
6.1.6 Inova Diagnostics Inc.
6.1.7 Myriad Genetics
6.1.8 Siemens Healthineers Inc.
6.1.9 Thermo Fisher Scientific
6.1.10 Trinity Biotech
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Firms Talked about
For extra details about this report go to https://www.researchandmarkets.com/r/813nw3
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wooden, Senior Press Supervisor firstname.lastname@example.org For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900